Wieland Aaron, Belden Laura, Cunningham Michael
Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA 02116, USA.
Otolaryngol Head Neck Surg. 2009 Apr;140(4):542-547. doi: 10.1016/j.otohns.2008.12.016.
To determine the current practice of pediatric otolaryngologists on a national level and general otolaryngologists on a regional level regarding preoperative coagulation screening prior to adenotonsillectomy.
A five-question survey of members of the American Society of Pediatric Otolaryngology (ASPO) and the Massachusetts Society of Otolaryngology-Head and Neck Surgery (MSO-HNS).
Surveys results were analyzed to determine current preoperative screening practices relative to awareness of screening recommendations published in the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) 1999 Clinical Indicators Compendium.
The survey response rate was 27 percent (54/190) and 29 percent (76/260) for MSO-HNS and ASPO members, respectively. In patients with no known bleeding risk, 21 percent of respondents continue to obtain coagulation screening including, at a minimum, a partial thromboplastin time and a prothrombin time. MSO-HNS respondents reported ordering more preoperative coagulation studies than did ASPO respondents (35% vs 10%). Interestingly awareness of the AAO-HNS consensus statement was similar between the two groups and did not impact screening practices.
The survey results indicate a discrepancy between current practice relative to pre-adenotonsillectomy coagulation screening and the recommendations of the AAO-HNS 1999 consensus statement.
确定全国范围内儿科耳鼻喉科医生以及地区范围内普通耳鼻喉科医生在腺样体扁桃体切除术前进行凝血筛查的当前做法。
对美国儿科耳鼻喉科学会(ASPO)和马萨诸塞州耳鼻喉科-头颈外科学会(MSO-HNS)的成员进行了一项包含五个问题的调查。
对调查结果进行分析,以确定当前术前筛查做法与美国耳鼻喉科-头颈外科学会(AAO-HNS)1999年临床指标汇编中发布的筛查建议的知晓情况之间的关系。
MSO-HNS和ASPO成员的调查回复率分别为27%(54/190)和29%(76/260)。在无已知出血风险的患者中,21%的受访者继续进行凝血筛查,至少包括部分凝血活酶时间和凝血酶原时间。MSO-HNS的受访者报告术前进行凝血检查的次数比ASPO的受访者多(35%对10%)。有趣的是,两组对AAO-HNS共识声明的知晓情况相似,且这并未影响筛查做法。
调查结果表明,当前腺样体扁桃体切除术前凝血筛查的做法与AAO-HNS 1999年共识声明的建议之间存在差异。